Susan Fish

593 total citations
29 papers, 454 citations indexed

About

Susan Fish is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Susan Fish has authored 29 papers receiving a total of 454 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Oncology, 14 papers in Pulmonary and Respiratory Medicine and 6 papers in Molecular Biology. Recurrent topics in Susan Fish's work include Colorectal Cancer Treatments and Studies (13 papers), Lung Cancer Treatments and Mutations (9 papers) and Cancer Treatment and Pharmacology (7 papers). Susan Fish is often cited by papers focused on Colorectal Cancer Treatments and Studies (13 papers), Lung Cancer Treatments and Mutations (9 papers) and Cancer Treatment and Pharmacology (7 papers). Susan Fish collaborates with scholars based in United States, Italy and Australia. Susan Fish's co-authors include Robert H. Abeles, E. Dawn Flick, Herbert I. Hurwitz, Tanios Bekaii‐Saab, Allen Lee Cohn, Robert W. Myers, Jonathan W. Wray, Nancy Roach, Johanna C. Bendell and Yong Mun and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and Biochemistry.

In The Last Decade

Susan Fish

24 papers receiving 435 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Susan Fish United States	11	226	159	149	60	37	29	454
Janelle J. Bruinsma United States	7	152 0.7×	138 0.9×	82 0.6×	134 2.2×	38 1.0×	12	560
Ruba Al‐Abdulla Spain	12	179 0.8×	216 1.4×	51 0.3×	35 0.6×	113 3.1×	20	465
Xuelan Zuo China	9	82 0.4×	262 1.6×	46 0.3×	52 0.9×	22 0.6×	25	516
Xiuling Li China	14	108 0.5×	228 1.4×	82 0.6×	24 0.4×	26 0.7×	29	468
Fuyumi Yamamoto Japan	8	70 0.3×	207 1.3×	231 1.6×	40 0.7×	45 1.2×	8	591
Yanli Song China	13	47 0.2×	204 1.3×	254 1.7×	27 0.5×	55 1.5×	41	579
Ellen M. van der Aar Netherlands	9	148 0.7×	172 1.1×	128 0.9×	8 0.1×	21 0.6×	14	553
Qiaonan Shan China	12	173 0.8×	305 1.9×	63 0.4×	72 1.2×	73 2.0×	16	547
Kazuo Fukutome Japan	16	134 0.6×	304 1.9×	134 0.9×	24 0.4×	118 3.2×	28	668
Seiji Doi Japan	12	511 2.3×	365 2.3×	177 1.2×	10 0.2×	64 1.7×	20	737

Countries citing papers authored by Susan Fish

Since Specialization

Citations

This map shows the geographic impact of Susan Fish's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Susan Fish with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Susan Fish more than expected).

Fields of papers citing papers by Susan Fish

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Susan Fish. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Susan Fish. The network helps show where Susan Fish may publish in the future.

Co-authorship network of co-authors of Susan Fish

This figure shows the co-authorship network connecting the top 25 collaborators of Susan Fish. A scholar is included among the top collaborators of Susan Fish based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Susan Fish. Susan Fish is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Huang, Allen, et al.. (2025). A Clinical Care Pathway for Patients With Chronic Mechanical Low Back Pain Having Restorative Neurostimulation for Multifidus Muscle: Description, Patient Compliance, Clinical Outcomes, and Satisfaction in the First Two Years. Neuromodulation Technology at the Neural Interface. 28(4). 558–566.

Whittle, Ian R., et al.. (2024). Restorative Neurostimulation of the Multifidus for Chronic Low Back Pain After Prior Lumbar Spinal Surgery: A Single-Center, Consecutive Case Series. Neuromodulation Technology at the Neural Interface. 28(2). 297–305.

Moslehi, Javid J., Mandar A. Aras, Vivian G. Oehler, et al.. (2023). Longitudinal, prospective cardiovascular and metabolic risk in treatment-naive patients with chronic myeloid leukemia in chronic phase (CML-CP) starting tyrosine kinase inhibitor (TKI) therapy in a real-world setting.. Journal of Clinical Oncology. 41(16_suppl). 7053–7053.

Ramasamy, Karthik, Hartmut Goldschmidt, Philippe Moreau, et al.. (2023). P945: REAL-WORLD CLINICAL OUTCOMES AMONG TRIPLE-CLASS EXPOSED RELAPSED REFRACTORY MULTIPLE MYELOMA PATIENTS IN US AND EUROPE: A PREAMBLE REGISTRY STUDY. HemaSphere. 7(S3). e642555a–e642555a.

Gandhi, Leena, Shirish M. Gadgeel, Alice T. Shaw, et al.. (2016). Time to response in patients with ALK+ NSCLC receiving alectinib in the phase II NP28673 and NP28761 studies. Annals of Oncology. 27. vi418–vi418. 1 indexed citations

Gadgeel, Shirish M., Alice T. Shaw, Fabrice Barlési, et al.. (2016). Cumulative incidence rates for CNS and non-CNS progression by baseline CNS metastases status using data from two alectinib phase II studies.. Journal of Clinical Oncology. 34(15_suppl). 9063–9063. 2 indexed citations

Woźniak, Agnieszka, Michael P. Kosty, Mohammad Jahanzeb, et al.. (2015). Clinical Outcomes in Elderly Patients with Advanced Non-small Cell Lung Cancer: Results from ARIES, a Bevacizumab Observational Cohort Study. Clinical Oncology. 27(4). 187–196. 21 indexed citations

Kosty, Michael P., Antoinette J. Wozniak, Mohammad Jahanzeb, et al.. (2015). Effectiveness and safety of post-induction phase bevacizumab treatment for patients with non-small-cell lung cancer: results from the ARIES observational cohort study. Targeted Oncology. 10(4). 509–516. 5 indexed citations

Hurwitz, Herbert I., Tanios Bekaii‐Saab, Johanna C. Bendell, et al.. (2014). Safety and Effectiveness of Bevacizumab Treatment for Metastatic Colorectal Cancer: Final Results from the Avastin® Registry – Investigation of Effectiveness and Safety (ARIES) Observational Cohort Study. Clinical Oncology. 26(6). 323–332. 24 indexed citations

10.

Bendell, Johanna C., et al.. (2014). Clinical Outcomes with First-Line Bevacizumab and Chemotherapy for Patients with Metastatic Colorectal Cancer and a History of Diabetes: Results From the Aries Observational Cohort Study. Annals of Oncology. 25. ii8–ii8. 1 indexed citations

11.

Lynch, Thomas J., David R. Spigel, Julie R. Brahmer, et al.. (2014). Safety and Effectiveness of Bevacizumab-Containing Treatment for Non–Small-Cell Lung Cancer: Final Results of the ARIES Observational Cohort Study. Journal of Thoracic Oncology. 9(9). 1332–1339. 44 indexed citations

12.

Martini, Paolo G.V., Susan Fish, Charles Bédard, et al.. (2013). Expression and Purification Methods for the Production of Recombinant Human Complement Component C2. Methods in molecular biology. 1100. 61–74. 1 indexed citations

13.

Cohn, Allen Lee, Herbert I. Hurwitz, Tanios Bekaii‐Saab, et al.. (2013). Effectiveness of bevacizumab (BV) beyond disease progression in metastatic colorectal cancer (mCRC): Analyses by sex in the ARIES observational cohort study (OCS).. Journal of Clinical Oncology. 31(4_suppl). 514–514. 1 indexed citations

14.

Bendell, Johanna C., Tanios Bekaii‐Saab, Allen Lee Cohn, et al.. (2012). Treatment Patterns and Clinical Outcomes in Patients With Metastatic Colorectal Cancer Initially Treated with FOLFOX–Bevacizumab or FOLFIRI–Bevacizumab: Results From ARIES, a Bevacizumab Observational Cohort Study. The Oncologist. 17(12). 1486–1495. 79 indexed citations

15.

Lynch, Thomas J., Mohammad Jahanzeb, David R. Spigel, et al.. (2012). Cumulative Exposure to Bevacizumab (BV) After Disease Progression (PD) Correlates with Survival in Non-Small Cell Lung Cancer (NSCLC): A Time-Dependent Analysis of the Aries Observational Cohort Study. Annals of Oncology. 23. ix420–ix420. 1 indexed citations

16.

Martini, Paolo G.V., Susan Fish, Knut Langsetmo, et al.. (2010). Recombinant human complement component C2 produced in a human cell line restores the classical complement pathway activity in-vitro: an alternative treatment for C2 deficiency diseases. BMC Immunology. 11(1). 43–43. 11 indexed citations

17.

Yang, Qing, Peter J. Tummino, Susan Fish, et al.. (2004). Enzymatic Characterization of the Pancreatic Islet-specific Glucose-6-Phosphatase-related Protein (IGRP). Journal of Biological Chemistry. 279(14). 13976–13983. 38 indexed citations

18.

Bembenek, Michael E., Ping Li, Linda Chee, et al.. (2003). Development of a High-Throughput Assay for Two Inositol-Specific Phospholipase Cs Using a Scintillation Proximity Format. Assay and Drug Development Technologies. 1(3). 435–443. 6 indexed citations

19.

Myers, Robert W., Jonathan W. Wray, Susan Fish, & Robert H. Abeles. (1993). Purification and characterization of an enzyme involved in oxidative carbon-carbon bond cleavage reactions in the methionine salvage pathway of Klebsiella pneumoniae.. Journal of Biological Chemistry. 268(33). 24785–24791. 60 indexed citations

20.

Stubbe, J., Susan Fish, & Robert H. Abeles. (1980). Are carboxylations involving biotin concerted or nonconcerted?. Journal of Biological Chemistry. 255(1). 236–242. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact